Short-term outcomes of intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration.

Hidetaka MatsumotoJunki HoshinoKosuke NakamuraTetsuhiro NagashimaHideo Akiyama

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2023)

Loading phase treatment with intravitreal faricimab appears to generally be safe and effective for improving visual acuity and reducing exudative changes in eyes with nAMD.

Keyphrases

age related macular degeneration
vascular endothelial growth factor
optical coherence tomography
endothelial cells
combination therapy